Pharma News

(24th July, 2014); Pharmacy Council of India (PCI) announced in its notification that MS Programmes are not approved by the PCI either for the purpose of registration as a pharmacist under the Pharmacy Act to practice the profession OR any other purpose like teaching in approved pharmacy institutions.

(24th July, 2014); Health Ministry prohibits the manufacture, sale and distribution of fixed dose combination (FDC) of Flupenthixol and Melitracen for human use on recommendations of the Drugs Technical Advisory Board (DTAB).

(21st July, 2014); Cardiologists at the Cedars-Sinai Heart Institute have developed a minimally invasive gene transplant procedure that changes unspecialized heart cells into “biological pacemaker” cells that keep the heart steadily beating.

[adsense:336x280:8701650588]

(21st July, 2014); Novartis & Google join together to develop smart contact lens which will be useful in monitoring blood sugar level for diabetic patients and restore focusing capacity of eyes in patients with presbyopia. Alcon, eye care division of Novartis, has entered into an agreement with a division of Google Inc. to in-license its “smart lens” technology for all ocular medical uses.

(Business Wire India; 18th July, 2014); For three-year-old Sneha, life is a struggle in continuity. A patient of Thalassemia major, Sneha battles death every single day. Her parents, despite being advised to undergo medical tests to diagnose her condition when she was in her mother’s womb, chose to disregard this warning. Now, this unawareness and lack of understanding might cost them dear. Unfortunately, they lost their four-year-old son two years ago due to the same blood disorder.

(17th July, 2014); Researchers from Salk discovered new and more effective diabetic drug which could lead for safe & new generation of anti-diabetic drugs. They injected single injection of the protein FGF1 which is enough to restore blood sugar levels to a healthy range for more than two days.

(15th July, 2014); Study published by researchers shown that use of antibiotics is increasing day by day across the world. Unsurprisingly India is the largest consumer of antibiotics in 2010. As per study, use is not being effectively monitored by health officials, from doctors to hospital workers to clinicians, noted the researchers. Consequently, antibiotic use is both rampant and less targeted. That reality is driving antibiotic resistance at an unprecedented rate.

(15th July, 2014); The first dengue vaccine candidate (CYD-TDV) to reach phase 3 clinical testing has shown moderate protection (56%) against the disease in Asian children, according to new research published in The Lancet.

(14th July, 2014); NIPER, Hyderbad is all set to develop National Centre for Research & Development in Bulk Drug (NCRDBD) for filling up gap in Research and Development in bulk drugs. The over all project costs around more than 52 crore rupees and with an operating cost of over 37 crore rupees for five years.

(11th July, 2014); Recent research asking questions to prior studies which stated that one drink per day may promote cardiovascular health. As per recent research published in The BMJ led by the Perelman School of Medicine at the University of Pennsylvania, reducing the amount of alcoholic beverages consumed, even for light-to-moderate drinkers, may improve cardiovascular health, including a reduced risk of coronary heart disease, lower body mass index (BMI) and blood pressure.